Yali Zhu

2.2k total citations
58 papers, 1.6k citations indexed

About

Yali Zhu is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yali Zhu has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Epidemiology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yali Zhu's work include Herpesvirus Infections and Treatments (9 papers), Advanced Breast Cancer Therapies (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yali Zhu is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), Advanced Breast Cancer Therapies (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yali Zhu collaborates with scholars based in United States, China and United Kingdom. Yali Zhu's co-authors include Paul Statkevich, Karen Small, Rajat Bannerji, Deborah S. Parris, Teddy Kosoglou, Biao Ding, Da Zhang, David L. Cutler, Yijun Qi and Melton B. Affrime and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Yali Zhu

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yali Zhu United States 23 523 522 299 257 246 58 1.6k
Jaudah Al‐Maghrabi Saudi Arabia 27 574 1.1× 851 1.6× 355 1.2× 342 1.3× 106 0.4× 177 2.2k
Alexandre Evrard France 25 711 1.4× 841 1.6× 173 0.6× 109 0.4× 346 1.4× 80 1.9k
Axel Sauerbrey Germany 25 1.1k 2.1× 1.3k 2.5× 178 0.6× 174 0.7× 115 0.5× 72 2.6k
Jun Hayashi Japan 26 345 0.7× 622 1.2× 356 1.2× 336 1.3× 73 0.3× 149 2.3k
Édith Beaulieu Canada 21 578 1.1× 529 1.0× 127 0.4× 128 0.5× 61 0.2× 35 1.6k
Aldo Cavallini Italy 26 357 0.7× 664 1.3× 271 0.9× 339 1.3× 132 0.5× 69 1.8k
Zodwa Dlamini South Africa 22 531 1.0× 869 1.7× 161 0.5× 168 0.7× 52 0.2× 110 2.0k
Jianda Hu China 25 699 1.3× 902 1.7× 130 0.4× 100 0.4× 114 0.5× 211 2.5k
Clark M. Henderson United States 16 850 1.6× 652 1.2× 301 1.0× 204 0.8× 54 0.2× 28 1.7k
Yuan Zhou China 26 434 0.8× 1.3k 2.5× 185 0.6× 123 0.5× 45 0.2× 102 2.2k

Countries citing papers authored by Yali Zhu

Since Specialization
Citations

This map shows the geographic impact of Yali Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Zhu more than expected).

Fields of papers citing papers by Yali Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Zhu. The network helps show where Yali Zhu may publish in the future.

Co-authorship network of co-authors of Yali Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yali Zhu. A scholar is included among the top collaborators of Yali Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Zhu. Yali Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Huifang, et al.. (2025). YOLO-DS: a detection model for desert shrub identification and coverage estimation in UAV remote sensing. Journal of Forestry Research. 36(1).
2.
Gao, Yue, Shujun Zhang, Jiajun Li, et al.. (2020). Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Bioscience Biotechnology and Biochemistry. 84(11). 2228–2240. 22 indexed citations
3.
Xiao, Qing, Shujun Zhang, Jiajun Li, et al.. (2020). Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes. Chemico-Biological Interactions. 324. 109062–109062. 13 indexed citations
4.
Mita, Monica, Alain C. Mita, Jennifer L. Moseley, et al.. (2017). Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies. British Journal of Cancer. 117(9). 1258–1268. 48 indexed citations
5.
Zhu, Yali, et al.. (2017). Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis. The American Journal of the Medical Sciences. 354(2). 182–189. 16 indexed citations
6.
Nemunaitis, John, Karen Small, Paul T. Kirschmeier, et al.. (2013). A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies. Journal of Translational Medicine. 11(1). 259–259. 105 indexed citations
7.
Stephenson, Joe, John Nemunaitis, Anil A. Joy, et al.. (2013). Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer. Lung Cancer. 83(2). 219–223. 81 indexed citations
8.
Zhu, Yali, et al.. (2012). Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells. Journal of Virology. 86(6). 3038–3049. 25 indexed citations
9.
Zhu, Yali, Zetang Wu, M. Cristina Cardoso, & Deborah S. Parris. (2010). Processing of Lagging-Strand Intermediates In Vitro by Herpes Simplex Virus Type 1 DNA Polymerase. Journal of Virology. 84(15). 7459–7472. 8 indexed citations
10.
Castañeda, Carlos A., Kellen L. Meadows, Michael A. Morse, et al.. (2010). Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 67(2). 455–463. 17 indexed citations
11.
Diez, Blanca, Paul Statkevich, Yali Zhu, et al.. (2009). Evaluation of the exposure equivalence of oral versus intravenous temozolomide. Cancer Chemotherapy and Pharmacology. 65(4). 727–734. 44 indexed citations
12.
Hanes, Jeremiah W., Yali Zhu, Deborah S. Parris, & Kenneth A. Johnson. (2007). Enzymatic Therapeutic Index of Acyclovir. Journal of Biological Chemistry. 282(34). 25159–25167. 14 indexed citations
13.
Zhu, Yali, et al.. (2007). Mechanisms by which herpes simplex virus DNA polymerase limits translesion synthesis through abasic sites. DNA repair. 7(1). 95–107. 10 indexed citations
14.
Cortes, Jörge E., Elias Jabbour, George Q. Daley, et al.. (2007). Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single‐agent therapy with imatinib. Cancer. 110(6). 1295–1302. 40 indexed citations
15.
Kosoglou, Teddy, Paul Statkevich, Bo Yang, et al.. (2004). Pharmacodynamic interaction between ezetimibe and rosuvastatin. Current Medical Research and Opinion. 20(8). 1185–1195. 49 indexed citations
16.
Cortes, Jörge E., Susan O’Brien, Srđan Verstovšek, et al.. (2004). Phase I Study of Lonafarnib (SCH66336) in Combination with Imatinib for Patients (Pts) with Chronic Myeloid Leukemia (CML) after Failure to Imatinib.. Blood. 104(11). 1009–1009. 10 indexed citations
17.
Zhu, Yali, et al.. (2002). Movement of Potato Spindle Tuber Viroid Reveals Regulatory Points of Phloem-Mediated RNA Traffic. PLANT PHYSIOLOGY. 130(1). 138–146. 79 indexed citations
18.
19.
Kosoglou, Teddy, Ingo Meyer, Enrico P. Veltri, et al.. (2002). Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. British Journal of Clinical Pharmacology. 54(3). 309–319. 91 indexed citations
20.
Matsuda, Yoshie, Genqing Liang, Yali Zhu, et al.. (2002). The Commelina yellow mottle virus promoter drives companion-cell-specific gene expression in multiple organs of transgenic tobacco. PROTOPLASMA. 220(1-2). 51–58. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaudah Al‐Maghrabi Breakdown of academic impact, for papers by Alexandre Evrard Breakdown of academic impact, for papers by Axel Sauerbrey Breakdown of academic impact, for papers by Jun Hayashi Breakdown of academic impact, for papers by Édith Beaulieu Breakdown of academic impact, for papers by Aldo Cavallini Breakdown of academic impact, for papers by Zodwa Dlamini Breakdown of academic impact, for papers by Jianda Hu Breakdown of academic impact, for papers by Clark M. Henderson Breakdown of academic impact, for papers by Yuan Zhou
Rankless by CCL
2026